BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28803690)

  • 1. New insights into non-conventional epitopes as T cell targets: The missing link for breaking immune tolerance in autoimmune disease?
    Harbige J; Eichmann M; Peakman M
    J Autoimmun; 2017 Nov; 84():12-20. PubMed ID: 28803690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune recognition of citrullinated epitopes.
    Nguyen H; James EA
    Immunology; 2016 Oct; 149(2):131-8. PubMed ID: 27531825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes.
    van Lummel M; Duinkerken G; van Veelen PA; de Ru A; Cordfunke R; Zaldumbide A; Gomez-Touriño I; Arif S; Peakman M; Drijfhout JW; Roep BO
    Diabetes; 2014 Jan; 63(1):237-47. PubMed ID: 24089515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell epitopes and post-translationally modified epitopes in type 1 diabetes.
    McGinty JW; Marré ML; Bajzik V; Piganelli JD; James EA
    Curr Diab Rep; 2015 Nov; 15(11):90. PubMed ID: 26370701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
    van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
    Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of glycans on T-cell tolerance to glycosylated self-antigens.
    Purcell AW; van Driel IR; Gleeson PA
    Immunol Cell Biol; 2008 Oct; 86(7):574-9. PubMed ID: 18626489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.
    Di Lorenzo TP; Peakman M; Roep BO
    Clin Exp Immunol; 2007 Apr; 148(1):1-16. PubMed ID: 17349009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
    Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
    Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).
    Wagner DH
    Clin Exp Immunol; 2016 Sep; 185(3):271-80. PubMed ID: 27271348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantigens in thyroid diseases.
    Dawe K; Hutchings P; Champion B; Cooke A; Roitt I
    Springer Semin Immunopathol; 1993; 14(3):285-307. PubMed ID: 7679802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
    Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
    J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance.
    James EA; Pietropaolo M; Mamula MJ
    Diabetes; 2018 Jun; 67(6):1035-1042. PubMed ID: 29784651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of autoimmunity in type 1 diabetes and type 1.5 overlap with type 2 diabetes.
    McDevitt HO
    Diabetes; 2005 Dec; 54 Suppl 2():S4-10. PubMed ID: 16306338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4
    Marre ML; McGinty JW; Chow IT; DeNicola ME; Beck NW; Kent SC; Powers AC; Bottino R; Harlan DM; Greenbaum CJ; Kwok WW; Piganelli JD; James EA
    Diabetes; 2018 Jul; 67(7):1356-1368. PubMed ID: 29654212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into autoimmunity gained from structural analysis of MHC-peptide complexes.
    Wucherpfennig KW
    Curr Opin Immunol; 2001 Dec; 13(6):650-6. PubMed ID: 11677085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.
    Durinovic-Belló I; Schlosser M; Riedl M; Maisel N; Rosinger S; Kalbacher H; Deeg M; Ziegler M; Elliott J; Roep BO; Karges W; Boehm BO
    Diabetologia; 2004 Mar; 47(3):439-450. PubMed ID: 14745491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals.
    Naquet P; Ellis J; Tibensky D; Kenshole A; Singh B; Hodges R; Delovitch TL
    J Immunol; 1988 Apr; 140(8):2569-78. PubMed ID: 2451692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.
    Miyadera H; Tokunaga K
    J Hum Genet; 2015 Nov; 60(11):697-702. PubMed ID: 26290149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitopes recognized by CBV4 responding T cells: effect of type 1 diabetes and associated HLA-DR-DQ haplotypes.
    Marttila J; Hyöty H; Näntö-Salonen K; Simell O; Ilonen J
    Virology; 2004 Feb; 319(1):27-35. PubMed ID: 14967485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex.
    Kosmopoulou A; Vlassi M; Stavrakoudis A; Sakarellos C; Sakarellos-Daitsiotis M
    J Comput Chem; 2006 Jul; 27(9):1033-44. PubMed ID: 16639700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.